SEC Form 4 · accession 0001209191-16-144211
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen M. Thackray
Officer — VP Clinical Development, CMO
Period of report
Oct 3, 2016
Accepted (ET)
Oct 4, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 3, 2016 | S | 3,900 | $7.00 | D | 156,715 | D | |
| Common Stock | Oct 3, 2016 | S | 100 | $7.01 | D | 156,615 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2016.